While the transfusion–hepcidin axis problem in MDS patients has been briefly discussed in the subsection on cohort studies, this section of our manuscript integrates and summarizes these data, irrespective of the type of study. The gene discussed is HAMP; the disease is myelodysplastic syndrome.